세계의 생식 유전학 시장 보고서(2025년)

Reproductive genetics is a branch of genetics that studies how genetic factors influence reproduction and the transmission of hereditary traits. It focuses on the genetic makeup of individuals involved in reproduction, examining how genes and chromosomes affect fertility, conception, and embryo development. This field explores the role of inherited genetic variations and their impact on reproductive health, with the goal of improving understanding of the biological processes underlying human reproduction and heredity.

The main product types of reproductive genetics are kits, laboratory-developed tests (LDTs), and reagents and consumables. Kits refer to standardized diagnostic tools designed to detect genetic variations relevant to reproductive health. The technologies used include polymerase chain reaction (PCR), next-generation sequencing (NGS), in-situ hybridization (ISH), and microarray analysis. These tools are applied in the detection of aneuploidy, single-gene disorders, structural chromosomal abnormalities, and other conditions. They are used by a range of end users, including hospitals, diagnostic laboratories, fertility clinics, and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The reproductive genetics market research report is one of a series of new reports from The Business Research Company that provides reproductive genetics market statistics, including the reproductive genetics industry global market size, regional shares, competitors with the reproductive genetics market share, detailed reproductive genetics market segments, market trends, and opportunities, and any further data you may need to thrive in the reproductive genetics industry. This reproductive genetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The reproductive genetics market size has grown rapidly in recent years. It will grow from $6.83 billion in 2024 to $7.91 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to the increasing demand for in vitro fertilization (IVF) procedures, the rising prevalence of genetic disorders, the growing maternal age, expanding awareness of prenatal screening, and increasing government initiatives in genetic research.

The reproductive genetics market size is expected to see rapid growth in the next few years. It will grow to $14.07 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to the growing adoption of assisted reproductive technologies (ART), the rising focus on personalized medicine, the increasing use of non-invasive prenatal testing (NIPT), the expansion of the fertility tourism market, and increasing investments in genetic counseling services. Major trends in the forecast period include advancements in genomic sequencing technologies, innovations in embryo screening techniques, developments in artificial intelligence (AI) for reproductive genetics, research and development in gene editing, and technological integration in fertility clinics.

The rising number of genetic disorders is expected to drive the growth of the reproductive genetics market in the coming years. Genetic disorders are medical conditions caused by abnormalities in an individual's deoxyribonucleic acid, which may range from a single gene mutation to broader chromosomal defects. The increase in these disorders is contributing to the demand for reproductive genetic testing, as families seek early insights to reduce uncertainty, make informed reproductive decisions, and prevent the transmission of inherited conditions. Reproductive genetics plays a vital role in identifying and managing genetic disorders, helping families take preventive steps and reduce the risk of passing conditions to future generations. For example, in July 2024, Cystic Fibrosis Australia, a national consumer organization, reported that the number of individuals with Cystic Fibrosis in the Australian Cystic Fibrosis Data Registry rose from 3738 in 2022 to 3798 in 2023, marking a 1.6 percent increase. As a result, the rising occurrence of genetic disorders is expected to support the growth of the reproductive genetics market.

Leading companies in the reproductive genetics market are focusing on creating advanced methods such as comprehensive multi-trait embryo comparison to provide prospective parents with tools for more accurate and individualized embryo selection. Comprehensive multi-trait embryo comparison refers to the process of evaluating and ranking multiple embryos based on a broad spectrum of hereditary conditions and complex traits, offering more informed and personalized decision-making during in vitro fertilization. For instance, in June 2025, Nucleus Genomics Inc., a biotechnology company based in the United States, introduced Nucleus Embryo, a cutting-edge reproductive genetics platform that enables in vitro fertilization patients to assess and compare up to twenty embryos based on more than nine hundred hereditary conditions along with complex characteristics such as appearance, cognitive ability, and mental health through polygenic scoring. This development represents a significant advancement beyond traditional genetic screening, granting parents greater control in embryo selection and raising ethical discussions around genetic optimization and trait selection.

In January 2024, Natera Inc., a genetic testing and diagnostics company based in the United States, acquired health assets from Invitae Corporation for a total of fifty-two point five million dollars. This acquisition is intended to enhance Natera's reproductive genetics offerings by incorporating Invitae's non-invasive prenatal screening and carrier screening services, thereby improving support for both patients and healthcare professionals. Invitae Corporation is a genetic information company located in the United States that offers reproductive genetics services such as preimplantation genetic testing, carrier screening, and analysis related to miscarriage.

Major players in the reproductive genetics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Revvity Inc., Medicover AB, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., The Cooper Companies Inc., Vitrolife AB, BillionToOne Inc., Sophia Genetics SA, Eurofins Genomics India Private Limited, Invitae Corporation, Igenomix, Gonagen GmbH, and Darwin AG.

North America was the largest region in the reproductive genetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in reproductive genetics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the reproductive genetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reproductive genetics market consists of revenues earned by entities by providing services such as infertility genetic testing, genetic counselling, genomic data interpretation, and risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The reproductive genetics market also includes sales of cryopreservation media, embryo biopsy tools, and lab information management systems (LIMS). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Reproductive Genetics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on reproductive genetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for reproductive genetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The reproductive genetics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Kits; Laboratory Developed Tests (LDT); Reagents And Consumables
• 2) By Technology: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); In-Situ Hybridization (ISH); Microarray Analysis
• 3) By Application: Aneuploidy; Single Gene Disorder; Structural Chromosomal Abnormality; Other Applications
• 4) By End User: Hospitals; Diagnostic Laboratories; Fertility Clinics; Research Institutions
• Subsegments:
• 1) By Kits: Sample Collection Kits; Extraction Kits; Amplification Kits; Sequencing Kits; Hybridization Kits
• 2) By Laboratory Developed Tests: Carrier Screening Tests; Preimplantation Genetic Tests; Prenatal Diagnostic Tests; Aneuploidy Detection Tests; Single Gene Disorder Tests
• 3) By Reagents And Consumables: Enzymes; Buffers; Probes; Fluorescent Labels; Laboratory Plasticware
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; Revvity Inc.; Medicover AB; OPKO Health Inc.; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; The Cooper Companies Inc.; Vitrolife AB; BillionToOne Inc.; Sophia Genetics SA; Eurofins Genomics India Private Limited; Invitae Corporation; Igenomix; Gonagen GmbH; Darwin AG.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Reproductive Genetics Market Characteristics

3. Reproductive Genetics Market Trends And Strategies

4. Reproductive Genetics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Reproductive Genetics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Reproductive Genetics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Reproductive Genetics Market Growth Rate Analysis
• 5.4. Global Reproductive Genetics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Reproductive Genetics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Reproductive Genetics Total Addressable Market (TAM)

6. Reproductive Genetics Market Segmentation

• 6.1. Global Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits
• Laboratory Developed Tests (LDT)
• Reagents And Consumables
• 6.2. Global Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• In-Situ Hybridization (ISH)
• Microarray Analysis
• 6.3. Global Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aneuploidy
• Single Gene Disorder
• Structural Chromosomal Abnormality
• Other Applications
• 6.4. Global Reproductive Genetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Fertility Clinics
• Research Institutions
• 6.5. Global Reproductive Genetics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Collection Kits
• Extraction Kits
• Amplification Kits
• Sequencing Kits
• Hybridization Kits
• 6.6. Global Reproductive Genetics Market, Sub-Segmentation Of Laboratory Developed Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carrier Screening Tests
• Preimplantation Genetic Tests
• Prenatal Diagnostic Tests
• Aneuploidy Detection Tests
• Single Gene Disorder Tests
• 6.7. Global Reproductive Genetics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzymes
• Buffers
• Probes
• Fluorescent Labels
• Laboratory Plasticware

7. Reproductive Genetics Market Regional And Country Analysis

• 7.1. Global Reproductive Genetics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Reproductive Genetics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Reproductive Genetics Market

• 8.1. Asia-Pacific Reproductive Genetics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Reproductive Genetics Market

• 9.1. China Reproductive Genetics Market Overview
• 9.2. China Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Reproductive Genetics Market

• 10.1. India Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Reproductive Genetics Market

• 11.1. Japan Reproductive Genetics Market Overview
• 11.2. Japan Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Reproductive Genetics Market

• 12.1. Australia Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Reproductive Genetics Market

• 13.1. Indonesia Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Reproductive Genetics Market

• 14.1. South Korea Reproductive Genetics Market Overview
• 14.2. South Korea Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Reproductive Genetics Market

• 15.1. Western Europe Reproductive Genetics Market Overview
• 15.2. Western Europe Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Reproductive Genetics Market

• 16.1. UK Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Reproductive Genetics Market

• 17.1. Germany Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Reproductive Genetics Market

• 18.1. France Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Reproductive Genetics Market

• 19.1. Italy Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Reproductive Genetics Market

• 20.1. Spain Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Reproductive Genetics Market

• 21.1. Eastern Europe Reproductive Genetics Market Overview
• 21.2. Eastern Europe Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Reproductive Genetics Market

• 22.1. Russia Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Reproductive Genetics Market

• 23.1. North America Reproductive Genetics Market Overview
• 23.2. North America Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Reproductive Genetics Market

• 24.1. USA Reproductive Genetics Market Overview
• 24.2. USA Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Reproductive Genetics Market

• 25.1. Canada Reproductive Genetics Market Overview
• 25.2. Canada Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Reproductive Genetics Market

• 26.1. South America Reproductive Genetics Market Overview
• 26.2. South America Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Reproductive Genetics Market

• 27.1. Brazil Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Reproductive Genetics Market

• 28.1. Middle East Reproductive Genetics Market Overview
• 28.2. Middle East Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Reproductive Genetics Market

• 29.1. Africa Reproductive Genetics Market Overview
• 29.2. Africa Reproductive Genetics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Reproductive Genetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Reproductive Genetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Reproductive Genetics Market Competitive Landscape And Company Profiles

• 30.1. Reproductive Genetics Market Competitive Landscape
• 30.2. Reproductive Genetics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Reproductive Genetics Market Other Major And Innovative Companies

• 31.1. Revvity Inc.
• 31.2. Medicover AB
• 31.3. OPKO Health Inc.
• 31.4. Natera Inc.
• 31.5. Myriad Genetics Inc.
• 31.6. Fulgent Genetics Inc.
• 31.7. The Cooper Companies Inc.
• 31.8. Vitrolife AB
• 31.9. BillionToOne Inc.
• 31.10. Sophia Genetics SA
• 31.11. Eurofins Genomics India Private Limited
• 31.12. Invitae Corporation
• 31.13. Igenomix
• 31.14. Gonagen GmbH
• 31.15. Darwin AG

32. Global Reproductive Genetics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Reproductive Genetics Market

34. Recent Developments In The Reproductive Genetics Market

35. Reproductive Genetics Market High Potential Countries, Segments and Strategies

• 35.1 Reproductive Genetics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Reproductive Genetics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Reproductive Genetics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer